Wenandy L - Search Results

1

The immunogenicity of the hTERT540-548 peptide in cancer.

Wenandy L, Sørensen RB, Sengeløv L, Svane IM, thor Straten P, Andersen MH. Wenandy L, et al. Clin Cancer Res. 2008 Jan 1;14(1):4-7. doi: 10.1158/1078-0432.CCR-07-4590. Clin Cancer Res. 2008. PMID: 18172245 Review.

2

RhoC a new target for therapeutic vaccination against metastatic cancer.

Wenandy L, Sørensen RB, Svane IM, Thor Straten P, Andersen MH. Wenandy L, et al. Cancer Immunol Immunother. 2008 Dec;57(12):1871-8. doi: 10.1007/s00262-008-0517-2. Epub 2008 Apr 16. Cancer Immunol Immunother. 2008. PMID: 18415097 Free PMC article.

3

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial.

Berntsen A, Trepiakas R, Wenandy L, Geertsen PF, thor Straten P, Andersen MH, Pedersen AE, Claesson MH, Lorentzen T, Johansen JS, Svane IM. Berntsen A, et al. Among authors: wenandy l. J Immunother. 2008 Oct;31(8):771-80. doi: 10.1097/CJI.0b013e3181833818. J Immunother. 2008. PMID: 18779742 Clinical Trial.

4

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.

Junker N, Andersen MH, Wenandy L, Dombernowsky SL, Kiss K, Sørensen CH, Therkildsen MH, Von Buchwald C, Andersen E, Straten PT, Svane IM. Junker N, et al. Among authors: wenandy l. Cytotherapy. 2011 Aug;13(7):822-34. doi: 10.3109/14653249.2011.563291. Epub 2011 Mar 24. Cytotherapy. 2011. PMID: 21428850

5

Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope.

Andersen RS, Wenandy L, Sørensen RB, thor Straten P, Andersen MH. Andersen RS, et al. Among authors: wenandy l. Leukemia. 2008 Mar;22(3):668-9. doi: 10.1038/sj.leu.2404937. Epub 2007 Sep 6. Leukemia. 2008. PMID: 17805325 No abstract available.

6

The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2/neu protein (HER2) as a minor histocompatibility antigen (mHag).

Wenandy L, Kollgaard T, Letsch A, Andersen RS, Stather D, Seremet T, Svane IM, Vindeløv L, Andersen MH, thor Straten P. Wenandy L, et al. Leukemia. 2009 Oct;23(10):1926-9. doi: 10.1038/leu.2009.112. Epub 2009 May 21. Leukemia. 2009. PMID: 19458631 No abstract available.

7

Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope.

Thorn M, Wang M, Kløverpris H, Schmidt EG, Fomsgaard A, Wenandy L, Berntsen A, Brunak S, Buus S, Claesson MH. Thorn M, et al. Among authors: wenandy l. Cancer Immunol Immunother. 2007 Nov;56(11):1755-63. doi: 10.1007/s00262-007-0319-y. Epub 2007 Apr 27. Cancer Immunol Immunother. 2007. PMID: 17464507 Free PMC article.

8

Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b.

Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, Bonnal RJ, Birolo RS, Moro M, Crosti MC, Gruarin P, Maglie S, Marabita F, Mascheroni D, Parente V, Comelli M, Trabucchi E, De Francesco R, Geginat J, Abrignani S, Pagani M. Rossi RL, et al. Among authors: wenandy l. Nat Immunol. 2011 Jun 26;12(8):796-803. doi: 10.1038/ni.2057. Nat Immunol. 2011. PMID: 21706005

9

Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease.

Dong S, Maiella S, Xhaard A, Pang Y, Wenandy L, Larghero J, Becavin C, Benecke A, Bianchi E, Socié G, Rogge L. Dong S, et al. Among authors: wenandy l. Blood. 2013 Sep 5;122(10):1802-12. doi: 10.1182/blood-2013-02-482539. Epub 2013 Jul 1. Blood. 2013. PMID: 23818545 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page